NEW PHENYLSULFAMOYL BENZAMIDE DERIVATIVES AS BRADYKININ ANTAGONISTS

摘要

Disclosed are phenylsulfamoyl benzamide derivatives represented by general formula (I) such as 4-[2-(2,4-dichloro-phenoxy)phenylsulfamoyl]-N-{ [ (piperidin-4-ylmethyl)-carbamoyl]-methyl} -benzamide hydrochloride. Also disclosed is the use of the compounds of formula (I) for treating diseases which require the inhibition of a bradykinin receptor.